Skip to main content
SpringerLink
Log in

Pharmacotherapy is used to reduce opiate withdrawal symptoms and prevent relapse in patients addicted to heroin

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gonzalez G, Oliveto A, Kosten, et al. Treatment of heroin (diamorphine) addiction. Current approaches and future prospects. Drugs 2002; 62(9): 1331–43

    Article  PubMed  CAS  Google Scholar 

  2. Bammer G. Provision of diamorphine (heroin) by prescription for drug dependency: issues and recommendations. CNS Drugs 1999 Apr; 11(4): 253–62

    Article  Google Scholar 

  3. British National Formulary. No. 44. London: The Pharmaceutical Press, 2002 Sep

  4. Margolin A, Kosten TR. Opioid detoxification and maintenance with blocking agents. In: Miller NS, editor. Comprehensive handbook of drug and alcohol addiction. New York (NY): Marcel Dekker, 1991: 1127–47

    Google Scholar 

  5. Senay EC, Dorus W, Goldberg F, et al. Withdrawal from methadone maintenance. Arch Gen Psychiatry 1977; 34: 361–7

    Article  PubMed  CAS  Google Scholar 

  6. Committee for Proprietary Medicinal Products European Public Assessment Report (EPAR). OrLAAM [online] Available from URL: http://www.eudra.org/humandocs/Humans/EPAR/Orlaam/Orlaam.htm [Accessed 2003 Jul 18]

  7. Judson BA, Goldstein A. Levo-alpha-acetylmethadol (LAAM) in the treatment of heroin addicts. I. Dosage schedule for induction and stabilization. Drug Alcohol Depend 1979; 4: 461–6

    Article  PubMed  CAS  Google Scholar 

  8. Ling W, Charuvastra C, Kaim SC, et al. Methadyl acetate and methadone as maintenance treatments for heroin addicts. A veterans administration cooperative study. Arch Gen Psychiatry 1976; 33: 709–20

    Article  PubMed  CAS  Google Scholar 

  9. O’Connor PG, Carroll KM, Shi JM, et al. Three methods of opioid detoxification in a primary care setting. A randomized trial. Ann Intern Med 1997; 127: 526–30

    PubMed  Google Scholar 

  10. Thirion X, Micallef J, Barrau K, et al. Recent evolution in opiate dependence in France during generalisation of maintenance treatments. Drug Alcohol Depend 2001; 61: 281–5

    Article  PubMed  CAS  Google Scholar 

  11. Obadia Y, Perrin V, Feroni I, et al. Injecting misuse of buprenorphine among French drug users. Addiction 2001; 96: 267–72

    Article  PubMed  CAS  Google Scholar 

  12. Washton AM, Resnick RB. Clonidine for opiate detoxification: outpatient clinical trials. Am J Psychiatry 1980, 2

  13. Gerra G, Zaimovic A, Giusti F, et al. Lofexidine versus clonidine in rapid opiate detoxification. J Subst Abuse Treat 2001; 21: 11–7

    Article  PubMed  CAS  Google Scholar 

  14. Vining E, Kosten TR, Kleber HD. Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers. Br J Addiction 1988; 83: 567–75

    Article  CAS  Google Scholar 

  15. Kirchmayer U, Davoli M, Verster A. Naltrexone maintenance treatment for opioid dependence. Cochrane Database of Systematic Reviews 2 (CD001333), 2001

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pharmacotherapy is used to reduce opiate withdrawal symptoms and prevent relapse in patients addicted to heroin. Drugs Ther. Perspect 19, 13–17 (2003). https://doi.org/10.2165/00042310-200319090-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200319090-00005

Keywords

Search

Navigation